Risk factors for community-acquired bacterial meningitis

LF Lundbo, T Benfield - Infectious Diseases, 2017 - Taylor & Francis
Background: Bacterial meningitis is a significant burden of disease and mortality in all age
groups worldwide despite the development of effective conjugated vaccines. The …

Vaccinations for the HIV-infected adult: a review of the current recommendations, part I

NF Crum-Cianflone, E Sullivan - Infectious Diseases and Therapy, 2017 - Springer
Vaccination is a critical component for ensuring the health of those living with the human
immunodeficiency virus (HIV) by protection against vaccine-preventable diseases. Since …

[HTML][HTML] Risk factors for contracting invasive meningococcal disease and related mortality: a systematic literature review and meta-analysis

H Dubey, P Oster, MS Fazeli, S Guedes… - International Journal of …, 2022 - Elsevier
Objectives To describe risk factors (RFs) and quantify their effects in invasive meningococcal
disease (IMD) and associated mortality across all age groups based on the available …

The propositive study: Immunogenicity and safety of a four‐component recombinant protein‐based vaccine against MenB and a quadrivalent conjugate MenACWY …

C Isitt, A Bartolf, N Andrews, S Athaide… - HIV …, 2023 - Wiley Online Library
Background People living with HIV have been shown to have an increased risk of invasive
meningococcal disease. In some countries, meningococcal vaccines are now routinely …

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16

H Findlow, H Campbell, J Lucidarme… - …, 2019 - eurosurveillance.org
Background In 1999, the United Kingdom (UK) was the first country to introduce
meningococcal group C (MenC) conjugate vaccination. This vaccination programme has …

Meningococcal vaccination rates among people with a new diagnosis of HIV infection in the US

PK Ghaswalla, GS Marshall, LGS Bengtson… - JAMA Network …, 2022 - jamanetwork.com
Importance In the United States, individuals with HIV infection have been recommended to
receive a 2-dose series of the meningococcal A, C, W, Y (MenACWY) vaccine since 2016 …

Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function

F Martinón-Torres, E Bernatowska, A Shcherbina… - …, 2018 - publications.aap.org
BACKGROUND: The capsular group B meningococcal vaccine (4CMenB) is recommended
for children with complement deficiencies, asplenia, and splenic dysfunction; however, data …

Comorbidity increases the risk of invasive meningococcal disease in adults

LF Lundbo, ZB Harboe, H Sandholdt… - Clinical Infectious …, 2022 - academic.oup.com
Background Risk of invasive meningococcal disease (IMD) is increased in patients with
complement deficiency and human immunodeficiency virus (HIV) infection. Risk associated …

Meningococcal disease in patients with human immunodeficiency virus infection: a review of cases reported through active surveillance in the United States, 2000 …

CM Harris, HM Wu, J Li, HI Hall, A Lee… - Open Forum …, 2016 - academic.oup.com
Background Although human immunodeficiency virus (HIV) infection is an established risk
factor for several bacterial infections, the association between HIV infection and …

[HTML][HTML] Oral and anal carriage of Neisseria meningitidis among sexually active HIV-infected men who have sex with men in Denmark 2014–15

M Tinggaard, HC Slotved, K Fuursted… - International Journal of …, 2021 - Elsevier
Introduction Outbreaks of invasive meningococcal disease (IMD) among men who have sex
with men (MSM) caused by a hypervirulent, non-encapsulated Neisseria meningitidis (Nm) …